GGrantIndex
Sort

261,768 grants matching gene therapy

Controlling Tumor Immune Escape in Pancreatic Cancer using a Dual T Cell Product Strategy

$1,348,474
Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2025 · CA

Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain

$1,348,453
Denis Evseenko · University Of Southern California · R61 · FY2023 · NS

Bio-Analysis Core

$1,348,450
George A Kuchel · University Of Connecticut Sch Of Med/Dnt · U54 · FY2022 · AG

Mechanisms of recovery following traumatic brain injury

$1,348,354
W. Dalton Dalton Dietrich · University Of Miami School Of Medicine · P50 · FY2006 · NS

Mechanisms of recovery following traumatic brain injury

$1,348,353
University Of Miami School Of Medicine · P50 · FY2005 · NS

Mechanisms of recovery following traumatic brain injury

$1,348,353
University Of Miami School Of Medicine · P50 · FY2004 · NS

Mechanisms of recovery following traumatic brain injury

$1,348,352
University Of Miami School Of Medicine · P50 · FY2003 · NS

Determining and targeting mechanisms controlling cancer cell division

$1,348,323
Jan M Skotheim · Stanford University · P01 · FY2024 · CA

Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle

$1,348,086
Thomas Hope · Northwestern University At Chicago · R01 · FY2024 · AI

Novel Therapeutic Strategies for PKD

$1,347,884
Mount Sinai School Of Medicine Of Nyu · P01 · FY2003 · DK

EFFICACY OF DNA AND PROTEIN CO-IMMUNIZATION PROTOCOL TO PROTECT MACAQUES FORM SHIV INFECTION

$1,347,763
Marx Preston · Tulane University Of Louisiana · N01 · FY2016 · AI

ESTABLISHING A MUTANT MOUSE REGIONAL RESOURCE CENTER AT THE JACKSON LABORATORY

$1,347,750
Leah Rae B Donahue · Jackson Laboratory · U42 · FY2010 · RR

Establishing a Mutant Mouse Regional Resource Center at The Jackson Laboratory

$1,347,750
Leah Rae B Donahue · Jackson Laboratory · U42 · FY2010 · RR

Epidemiology of Dementia in the Framingham Study

$1,347,693
Sudha Seshadri · Boston University Medical Campus · R01 · FY2013 · AG

Addressing Shortcomings of AAV GeneTherapies for the Muscular Dystrophies

$1,347,536
Hugh Lee Sweeney · University Of Florida · P50 · FY2025 · HD

Angiogenic/neuroprotective molecules in eye diseases

$1,347,483
Xuri Li · National Eye Institute · ZIA · FY2009 · EY

Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease

$1,347,258
Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Molecular Gene and Radiation Therapies for Cancer

$1,347,203
Svend O Freytag · Henry Ford Health System · P01 · FY2007 · CA

SCLERODERMA CYCLOPHOSPHAMIDE OR TRANSPLANTION STUDY (SCOT)

$1,347,138
Keith M Sullivan · Duke University · N01 · FY2012 · AI

Resetting immune homeostasis: a non-invasive approach towards HIV eradication

$1,347,054
Rafick-Pierre Sekaly · Emory University · U01 · FY2020 · AI

Establishing an Alzheimer’s disease biomarker clock in Down syndrome using positron emission tomography and plasma analytes

$1,346,873
Matthew Zammit · University Of Wisconsin-Madison · RF1 · FY2025 · AG

T cell recognition of the MR1 presented microbial metabolome

$1,346,843
Erin June Adams · University Of Chicago · R01 · FY2021 · AI

Understanding the Role of the Host Response in HIVSIV Infection

$1,346,823
Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

The Center of Excellence in Addiction Studies (CEAS)

$1,346,821
Frank Porreca · University Of Arizona · P30 · FY2025 · DA

The Center of Excellence in Addiction Studies (CEAS)

$1,346,821
Frank Porreca · University Of Arizona · P30 · FY2023 · DA